Response of intracranial metastases to epidermal growth factor receptor tyrosine kinase inhibitors: it may all depend on EGFR mutations

MeSH terms

• Brain Neoplasms / drug therapy*
• Brain Neoplasms / secondary*
• Carcinoma, Non-Small-Cell Lung / drug therapy*
• Carcinoma, Non-Small-Cell Lung / secondary*
• ErbB Receptors / antagonists & inhibitors*
• ErbB Receptors / genetics*
• Erlotinib Hydrochloride
• Female
• Gefitinib
• Humans
• Lung Neoplasms / pathology
• Middle Aged
• Protein-Tyrosine Kinases / antagonists & inhibitors
• Quinazolines / therapeutic use
• Sequence Deletion*